APPLICATIONS PUBLISHED 30 JUNE 2004
Published: 10-Jan-2005
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Enhancing epidermal barrier development in skin
Unilever 1432399*
Use of guaiol for treating the skin
Ciba Specialty Chemicals 1432400*
Compsns for delivery of drug combinations
Celator Technologies 1432402*
Liposome loading with metal ions
Celator Technologies 1432403*
Edible compsn and dosable form comprising an edible shell
McNeil-PPC 1432404*
Ibuprofen salt emulsifiers and cream formulations containing same
MacroChem Corp 1432405*
Pharmaceutical compsn comprising a water/oil/water double emulsion incorporated in a solid support
Remedia 1432406*
Lisinopril compsns having large-particle DCPD
AstraZeneca 1432407*
Pharmaceutical compsns comprising colloidal silicon dioxide
Novartis 1432408*
Granulate or powder for producing coating or binding agents for medicaments
Roehm 1432409*
Process for the preparation of fast dissolving effervescent dosage form
Ranbaxy Laboratories 1432410*
Timed, sustained release multi-particulate dosage forms of propranolol
Eurand Pharmaceuticals 1432411*
Antioxidant combination compsn and use thereof
VSL Pharmaceuticals 1432412*
3,4-methylenedioxy-substituted chalcones as therapeutic agents
Cancer Research Technology 1432413*
Use of tazarotene for preparing a nail varnish for treating and/or preventing psoriasis and nail varnish containing same
Pierre Fabre Dermo-Cosmetique 1432414*
Substituted 2,5-diamidoindoles as ECE inhibitors for the treatment of cardiovascular diseases
Bayer HealthCare 1432415*
Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compsns containing them
Pharmacia Italia 1432416*
Substituted benzimidazole compounds and their use for the treatment of cancer
Aventis Pharma 1432417*
Treatment of hepatitis B virus infection with human monoclonal antibodies
XTL Biopharmaceuticals 1432418*
Aryl substituted pyridinecarboxamides and their use as sodium channel blockers
Euro-Celtique 1432419*
Benzimidazolidinone derivatives as muscarinic agents
Acadia Pharmaceuticals 1432420*
Quinoline derivatives as neuropeptide Y antagonists
F Hoffmann-La Roche 1432421*
Use of CKit inhibitors for the treatment of myeloma
Novartis 1432422*
Pharmaceutical combinations of PE-V inhibitors and other agents
Novartis 1432423*
Heterocyclic substituted 2-(4-phenoxy) pyridine derivatives and related compounds as sodium channel blockers for the treatment of neuronal damage and neurodegenerative conditions
Euro-Celtique 1432424*
A method of reducing the 'in vivo' cholesterol ester transfer protein mediated transfer of cholesteryl esters between high density lipoproteins (HDL) and low density lipoproteins (LDL)
Forbes Medi-Tech 1432425*
Use of unmethylated CPG
Actial Farmaceutica Lda 1432426*
Compsn of hypochlorous acid and its applications
Aquilabs 1432427*
Agent for colouring fibres containing keratin
Henkel Kommanditgesellschaft auf Aktien 1432428*
Inhibition of angiogenesis and destruction of angiogenic vessels with extracts of noni juice morinda citrofolia
Board of Supervisors of Louisiana State University and Agricultural and Mechanical College 1432429*
Pre-mixes of GLP-1 and basal insulin
Eli Lilly 1432430*
Methods and compsns for modulating interleukin-21 receptor activity
Genetics Institute 1432431*
A cancer treatment system
Zengen 1432432*
Antagonists
Novo Nordisk; DGI BioTechnologies 1432433*
Use of substances with oxytocin activity for the preparation of a pharmaceutical compsn against inflammation
Uvnaes-Moberg, Kerstin; Lundeberg, Thomas 1432434*
Enamel matrix protein compsns for modulating immune response
Biora Bioex AB 1432435*
Nutrient therapy for immuno-compromised patients
Millennium Biotechnologies 1432436*
Human tissue urokinase type plasminogen activator formulation
Global Biotech 1432437*
Use of rank antagonists to treat cancer
Immunex Corp 1432438*
Means for improving immune response
Moiogen 1432439*
Adjuvants for nucleic acid vaccines
Glaxo Group 1432440*
Use of HMGB1 for the activation of dendritic cells
Fondazione Centro San Raffaele del Monte Tabor 1432441*
Vaccine
GlaxoSmithKline Biologicals 1432442*
Angiotensin peptide-carrier conjugates and uses thereof
Cytos Biotechnology 1432443*
Anti-A-beta antibodies
Eli Lilly 1432444*
Treatment of chronic joint inflammation using an antibody against the CD3 antigen complex
Isis Innovation 1432445*
Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation and compsns useful for the treatment of such disorders
Genentech 1432446*
Combined compsns and methods for tumour vasculature coagulation and treatment
Board of Regents, The University of Texas System; Peregrine Pharmaceuticals 1432447*
Novel molecules of the HKID-1-related protein family and uses thereof
Millennium Pharmaceuticals 1432448*
Water-in-oil emulsions comprising vinyl polymers carrying acidic groups in side-chains, compsns and methods
3M Innovative Properties Co 1432449*
Therapeutically useful triethyleneglycol cholesterol oligonucleotides
Bioniche Life Sciences; Phillips, Nigel 1432450*
Production of fusion proteins and use for identifying binding molecules
Abgenomics 1432451*
Inhibition of Stat-1
Avontec 1432452*
Stilbene derivatives as their use for binding and imaging amyloid plaques
The Trustees of the University of Pennsylvania; Kung, Hank 1432453*
Methods for sterilising preparations containing albumin
Clearant 1432454*
